Tics and Tourette syndrome - surplus of actions rather than disorder?

Beste C, Münchau A.

Mov Disord. 2017 Dec 26. doi: 10.1002/mds.27244. [Epub ahead of print] No abstract available.

Tourette syndrome and risk of depression: a population-based cohort study in Taiwan.

Chou IC, Lin HC, Lin CC, Sung FC, Kao CH.

J Dev Behav Pediatr. 2013 Apr;34(3):181-5. doi: 10.1097/DBP.0b013e3182829f2b.

Trichotillomania is more related to Tourette disorder than to obsessive-compulsive disorder

Lamothe H, Baleyte JM, Mallet L, Pelissolo A.

Braz J Psychiatry. 2020 Jan-Feb;42(1):87-104. doi: 10.1590/1516-4446-2019-0471.

Exacerbation of tics after combining aripiprazole with pimozide: a case with Tourette Syndrome.

Mazlum B, Zaimoğlu S, Öztop DB.

J Clin Psychopharmacol. 2015 Jun;35(3):350-1. doi: 10.1097/JCP.0000000000000331. No abstract available.

Deep brain stimulation of the pallidum internum for Gilles de la Tourette syndrome: a patient-specific model-based simulation study of the electric field.

Wårdell K, Kefalopoulou Z, Diczfalusy E, Andersson M, Åström M, Limousin P, Zrinzo L, Hariz M.

Neuromodulation. 2015 Feb;18(2):90-6. doi: 10.1111/ner.12248.

The Effect of a New Therapy for Children with Tics Targeting Underlying Cognitive, Behavioral, and Physiological Processes.

Leclerc JB, O'Connor KP, J-Nolin G, Valois P, Lavoie ME.

Front Psychiatry. 2016 Aug 11;7:135. doi: 10.3389/fpsyt.2016.00135.

Korean adults' beliefs about and social distance toward attention-deficit hyperactivity disorder, Tourette syndrome, and autism spectrum disorder.

Park S, Lee Y, Kim CE.

Psychiatry Res. 2018 Nov;269:633-639. doi: 10.1016/j.psychres.2018.08.023. Epub 2018 Aug 12.

Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

Castellan Baldan L, Williams KA, Gallezot JD, Pogorelov V, Rapanelli M, Crowley M, Anderson GM, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza KE, Ercan-Sencicek AG, Krusong K, Leventhal BL, O

Neuron. 2014 Jan 8;81(1):77-90. doi: 10.1016/j.neuron.2013.10.052. Erratum in: Neuron. 2014 Jun 4;82(5):1186-7.

Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis.

Hollis C, Pennant M, Cuenca J, Glazebrook C, Kendall T, Whittington C, Stockton S, Larsson L, Bunton P, Dobson S, Groom M, Hedderly T, Heyman I, Jackson GM, Jackson S, Murphy T, Rickards H, Robertson

Health Technol Assess. 2016 Jan;20(4):1-450, vii-viii. doi: 10.3310/hta20040. Review.

Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies.

Egan CA, Marakovitz SE, O'Rourke JA, Osiecki L, Illmann C, Barton L, McLaughlin E, Proujansky R, Royal J, Cowley H, Rangel-Lugo M, Pauls DL, Scharf JM, Mathews CA; Tourette Syndrome Association Intern

Am J Med Genet B Neuropsychiatr Genet. 2012 Dec;159B(8):987-96. doi: 10.1002/ajmg.b.32107.

Dystonic tics in patients with Gilles de la Tourette syndrome.

Szejko N, Jakubczyk A, Dunalska A, Janik P.

Neurol Neurochir Pol. 2019;53(5):335-340. doi: 10.5603/PJNNS.a2019.0046. Epub 2019 Oct 17.

Bothersome tics in patients with chronic tic disorders: Characteristics and individualized treatment response to behavior therapy.

McGuire JF, Piacentini J, Scahill L, Woods DW, Villarreal R, Wilhelm S, Walkup JT, Peterson AL.

Behav Res Ther. 2015 Jul;70:56-63. doi: 10.1016/j.brat.2015.05.006.

A meta-analysis of behavior therapy for Tourette Syndrome.

McGuire JF, Piacentini J, Brennan EA, Lewin AB, Murphy TK, Small BJ, Storch EA.

J Psychiatr Res. 2014 Mar;50:106-12. doi: 10.1016/j.jpsychires.2013.12.009.

TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette Syndrome.

Forde NJ, Kanaan AS, Widomska J, Padmanabhuni SS, Nespoli E, Alexander J, Rodriguez Arranz JI, Fan S, Houssari R, Nawaz MS, Rizzo F, Pagliaroli L, Zilhäo NR, Aranyi T, Barta C, Boeckers TM, Boomsma DI

Front Neurosci. 2016 Aug 23;10:384. doi: 10.3389/fnins.2016.00384.

Glutamatergic modulatory therapy for Tourette syndrome.

Singer HS, Morris C, Grados M.

Med Hypotheses. 2010 May;74(5):862-7. doi: 10.1016/j.mehy.2009.11.028.